• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: chemotherapy

  • Front Line Therapy in Non-Small Cell Lung Cancer 0
    • in Oncology
    • — 17 Mar, 2008

    Front Line Therapy in Non-Small Cell Lung Cancer

    Nick Thatcher
    Nick Thatcher

    NICK THATCHER, Christie Hospital, Manchester
    There is a proven benefit in survival if you give your patients cis-platinum based chemotherapy after resection for non-small cell lung cancer. Nick Thatcher emphasized this fact at the beginning of his
    …
    Read more
    Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma? 0
    • in General Medicine
    • — 27 Feb, 2008

    Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?

    Timothy Illidge
    Timothy Illidge

    Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
    TIMOTHY ILLIDGE, Christie Hospital, Manchester
    Radioconjugated antibodies are showing great promise for treating follicular lymphoma which has failed chemotherapy combined with rituximab. That’s according to Tim
    …
    Read more
  • Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer 0
    • in Oncology
    • — 15 Feb, 2008

    Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer

    David Cunningham
    David Cunningham
    REFERENCE: Abstract 3012, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    DAVID CUNNINGHAM, Royal Marsden Hospital, London
    The oral agent capeticabine is just as effective as fluorouracil for treating patients whose metastatic colorectal cancer
    …
    Read more
    Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer 0
    • in Oncology
    • — 27 Jan, 2008

    Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer

    Charles Hsu
    Charles Hsu

    CHARLES HSU, Johns Hopkins University, Baltimore
    Big improvements in overall survival were achieved by combining radiation with adjuvant chemotherapy for patients with pancreas cancer in a dtudy reported to the conference in Orlando. Charles Hsu told Peter Goodwin
    …
    Read more
  • Early Breast Cancer Chemotherapy: Long Term Findings 0
    • in News
    • — 8 Jan, 2008

    Early Breast Cancer Chemotherapy: Long Term Findings

    Richard Peto
    Richard Peto

    REFERENCE: Lancet 371:29-40; January 5, 2008
    RICHARD PETO, Oxford University
    The prospect of cutting breast cancer mortality in half throughout the world is held out by Richard Peto of the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). He
    …
    Read more
    • in Oncology
    • — 10 Dec, 2007

    Live Report from ASH:
    Oblimersen Extends Survival in Chronic Lymphocytic Leukemia

    Susan O’Brien
    Susan O’Brien

    SUSAN O’BRIEN, MD Anderson Cancer Center, Houston
    For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamide chemotherapy. Susan O’Brien presented data from this phase III trial to the American Society of Hematology
    …
    Read more
  • Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer 0
    • in Oncology
    • — 16 Nov, 2007

    Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

    Jean-Yves Douillard
    Jean-Yves Douillard
    Gordon McVie
    Gordon McVie

    REFERENCE: Abstracts: 6507 & 2LB, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    JEAN-YVES DOUILLARD, Centre René Gauducheau, Nante
    COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

    The vinca alkaloid vinflunine and
    …
    Read more
    Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer 0
    • in Oncology
    • — 16 Oct, 2007

    Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

    Jose Baselga
    Jose Baselga
    Gordon McVie
    Gordon McVie

    REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
    JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona
    COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

    Neoadjuvant trastuzumab for patients with HER2-positive
    …
    Read more
  • DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates 0
    • in General Medicine
    • — 21 Sep, 2007

    DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates

    Pedro Cahn
    Pedro Cahn

    REFERENCE: Abstract H-717, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires
    Etravirine provides a chance to rescue patients who are failing non-nucleoside regimens according to 24-week
    …
    Read more
    Hospital Hand Hygiene Program Successfully Rolled Out 0
    • in General Medicine
    • — 21 Sep, 2007

    Hospital Hand Hygiene Program Successfully Rolled Out

    Lindsay Grayson
    Lindsay Grayson

    REFERENCE: Abstract K-1374, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    LINDSAY GRAYSON, Austin Hospital, Victoria, Australia
    A hand hygiene campaign implemented in six hospitals in Victoria, Australia has saved lives from MRSA, and
    …
    Read more
  • BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns 0
    • in General Medicine
    • — 21 Sep, 2007

    BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns

    Jennifer Lavrrar, Jane Hata, Jeanette Block
    Jennifer Lavrrar, Jane Hata, Jeanette Block

    REFERENCE: Slide Session C2-1360, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    JANE HATA, bioMéríeux Inc, Durham
    Reports from the BORIS study call for ongoing surveillance of multi-drug resistant Acinetobacter
    …
    Read more
    Vancomycin: New Guidelines May Induce Kidney Damage 0
    • in Public Health
    • — 19 Sep, 2007

    Vancomycin: New Guidelines May Induce Kidney Damage

    Megan Nguyen
    Megan Nguyen

    REFERENCE: Poster Session 104 K-1096, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
    MEGAN NGUYEN, Western University in Pomona, California
    New vancomycin guidelines that recommend using higher doses may cause kidney damage according to
    …
    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: chemotherapy

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.